Fulcrum Therapeutics

-$0.28 (-3.85%) As of 4:32 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FULC and other ETFs, options, and stocks.

About FULC

Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company. The firm develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies.

CEO
Bryan E Stuart
Employees
73
Headquarters
Cambridge, Massachusetts
Founded
2015

FULC Key Statistics

Market Cap
286.02M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
209.45K
High Today
$7.33
Low Today
$7.00
Open Price
$7.17
Volume
23.06K
52 Week High
$18.38
52 Week Low
$6.85

FULC Earnings

-$0.83
-$0.55
-$0.28
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 17, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure